Metronidazole
Metronidazole is a nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa. (In Vitro) :Metronidazole displays inhibitory activity towards anaerobic protozoa Trichomonas vaginalis, Entamoeba histolytica, Giardia lamblia, and Balantidium coli.Metronidazole (4-8 μg/mL) inhibits anaerobic bacteria and shows good bactericidal activity.Metronidazole (0.1 μg/mL-0.01 mg/mL; 12-96 h) induces granular formation and triggers apoptosis in Blastocystis sp. (In Vivo) :Metronidazole (135 mg/kg/d; p.o.; 28 d) can cross the blood brain barrier, and exhibits neurotoxicity under long term administration in rats.Metronidazole (1 g/L; p.o.; 4 weeks) results skeletal muscle atrophy and changes the expression of genes involved in the muscle peripheral circadian rhythm machinery and metabolic regulation.
Product Specifications
CAS Number
443-48-1
Product Name Alternative
MNZ | NSC 50364 | NSC 69587
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO: 34 mg/mL (198.65 mM)
Smiles
O=[N+] (C1=CN=C (C) N1CCO) [O-]
Molecular Formula
C6H9N3O3
Molecular Weight
171.16
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2- (2-methyl-5-nitroimidazol-1-yl) ethanol
Available Sizes
Explore Other Products
Browse additional items from our catalog